BioSpace News Archive

Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for the year ended March 31, 2023, after the close of market on Tuesday, May 23, 2023.

Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists in treating complex cardiac arrhythmias such as atrial fibrillation (AF), today announced that the U.S. Food and Drug Administration (FDA) has cleared Volta AF-Xplorer™, an AI companion designed for the assessment of complex AF and atrial tachycardia (AT) procedures.

Sebela Women’s Health Inc. today announced positive results of a Phase 3 study demonstrating that investigational Copper 175 mm2 IUD met the primary efficacy outcome measurement of prevention of pregnancy through 3 years of use, with a cumulative 3-year Pearl Index (number of pregnancies per 100 women over 1 year) of 0.96 (95% CI, 0.59-1.48) or 99% efficacy.

Agilent Technologies Inc., announced the company intends to appeal the U.S. Patent and Trademarks Office Patent Trial and Appeal Board’s Final Written Decision in connection with the Inter Partes review of U.S. Patent Nos. 10,337,001 & 10,900,034.

Copernicus Therapeutics, Inc., today announced preliminary data, in collaboration with Northeastern University and Tufts University, that demonstrated plasmid GDNF DNA nanoparticles (pGDNF NPs) delivered intranasally bypass the blood-brain barrier to allow gene expression in brain cells, which ultimately results in a reduction in drug-seeking behaviors in rats.

BiomeSense, a biotech company unlocking the vast health benefits of the microbiome through novel “smart bathroom” hardware technology and advanced bioinformatics, announced the close of its oversubscribed $3 million funding round.

Plandai Biotechnology is pleased to announce a comprehensive rebranding initiative following the successful completion of its share exchange agreement with ByoPlanet, LLC.

GT Medical Technologies, Inc. announced receipt of the 1,000th order for GammaTile Therapy.

Glidewell announced a new partnership with LuxCreo, a leading 3D printing company in dental appliances based in San Francisco, to introduce the fastprint.io™ 3D Printing Solution.

A new era has launched for the Washington Permanente Medical Group, with the selection of its new executive medical director, Linda Tolbert, MD, JD, EdD, MPH, who officially began her position on May 15, 2023.